Gynaecology waiting lists in the UK have more than doubled since early 2020, with research indicating approximately 755,000 appointments are currently pending up from 360,400 before the pandemic. This suggests over 630,000 women are waiting for care related to conditions such as endometriosis, fibroids, menopause symptoms, and incontinence. Health leaders warn that the backlog is having a detrimental effect on women’s lives, with many unable to work or participate fully in daily activities.

The Royal College of Obstetricians and Gynaecologists (RCOG) has criticised the lack of priority given to women’s health, highlighting that gynaecology has one of the longest waiting lists among elective specialities. A recent report suggests the economic impact of untreated conditions, such as heavy periods and ovarian cysts, costs the UK economy nearly £11 billion annually due to workplace absences. RCOG is calling for increased and sustained investment in women's healthcare to address this crisis and prevent further deterioration of patients' health.

Some initiatives are underway to improve the situation, including the expansion of women’s health hubs and community-based care teams. Governments across the UK are also developing long-term women’s health plans, although progress has been slow. While recent NHS data shows a slight improvement in waiting times, the figures remain far worse than pre-pandemic levels, with over 22,000 patients now waiting more than a year for care.

Health ministers have pledged to address the issue, with commitments to invest in women’s health services. However, experts insist that immediate action is necessary to reduce waiting lists and prevent further harm. Improved access to timely diagnosis and treatment would not only benefit patients’ physical and mental wellbeing but also reduce the broader economic and societal costs of delayed care.